155 related articles for article (PubMed ID: 37695700)
1. Advances in the systemic therapy for recurrent meningiomas and the challenges ahead.
Li Y; Drappatz J
Expert Rev Neurother; 2023; 23(11):995-1004. PubMed ID: 37695700
[TBL] [Abstract][Full Text] [Related]
2. Current treatment options for meningioma.
Apra C; Peyre M; Kalamarides M
Expert Rev Neurother; 2018 Mar; 18(3):241-249. PubMed ID: 29338455
[TBL] [Abstract][Full Text] [Related]
3. Management of Atypical and Anaplastic Meningiomas.
Buttrick S; Shah AH; Komotar RJ; Ivan ME
Neurosurg Clin N Am; 2016 Apr; 27(2):239-47. PubMed ID: 27012388
[TBL] [Abstract][Full Text] [Related]
4. Current experimental therapies for atypical and malignant meningiomas.
Corona AM; Di L; Shah AH; Crespo R; Eichberg DG; Lu VM; Luther EM; Komotar RJ; Ivan ME
J Neurooncol; 2021 Jun; 153(2):203-210. PubMed ID: 33950341
[TBL] [Abstract][Full Text] [Related]
5. Atypical meningiomas.
Chen R; Aghi MK
Handb Clin Neurol; 2020; 170():233-244. PubMed ID: 32586495
[TBL] [Abstract][Full Text] [Related]
6. Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series.
Lou E; Sumrall AL; Turner S; Peters KB; Desjardins A; Vredenburgh JJ; McLendon RE; Herndon JE; McSherry F; Norfleet J; Friedman HS; Reardon DA
J Neurooncol; 2012 Aug; 109(1):63-70. PubMed ID: 22535433
[TBL] [Abstract][Full Text] [Related]
7. Necrosis is a consistent factor to recurrence of meningiomas: should it be a stand-alone grading criterion for grade II meningioma?
Góes P; Santos BFO; Suzuki FS; Salles D; Stávale JN; Cavalheiro S; de Paiva Neto MA
J Neurooncol; 2018 Apr; 137(2):331-336. PubMed ID: 29270884
[TBL] [Abstract][Full Text] [Related]
8. A narrative review of targeted therapies in meningioma.
Kim L
Chin Clin Oncol; 2020 Dec; 9(6):76. PubMed ID: 33353364
[TBL] [Abstract][Full Text] [Related]
9. Innovative treatments for meningiomas.
Graillon T; Tabouret E; Salgues B; Horowitz T; Padovani L; Appay R; Farah K; Dufour H; Régis J; Guedj E; Barlier A; Chinot O
Rev Neurol (Paris); 2023 Jun; 179(5):449-463. PubMed ID: 36959063
[TBL] [Abstract][Full Text] [Related]
10. World Health Organization Grade III Meningiomas: A Retrospective Study at an Academic Medical Center.
Sá-Marta E; Alves JL; Rebelo O; Barbosa M
World Neurosurg; 2021 May; 149():e877-e893. PubMed ID: 33516862
[TBL] [Abstract][Full Text] [Related]
11. Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases.
Palma L; Celli P; Franco C; Cervoni L; Cantore G
J Neurosurg; 1997 May; 86(5):793-800. PubMed ID: 9126894
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery.
Kim M; Lee DH; Kim Rn HJ; Cho YH; Kim JH; Kwon DH
Clin Neurol Neurosurg; 2017 Feb; 153():93-101. PubMed ID: 28081463
[TBL] [Abstract][Full Text] [Related]
13. Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea.
Schrell UM; Rittig MG; Anders M; Koch UH; Marschalek R; Kiesewetter F; Fahlbusch R
J Neurosurg; 1997 May; 86(5):840-4. PubMed ID: 9126900
[TBL] [Abstract][Full Text] [Related]
14. Landscape of genetic variants in sporadic meningiomas captured with clinical genomics.
Leclair NK; Shen E; Wu Q; Wolansky L; Becker K; Li L; Bulsara KR
Acta Neurochir (Wien); 2022 Sep; 164(9):2491-2503. PubMed ID: 35881312
[TBL] [Abstract][Full Text] [Related]
15. Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma.
Mason WP; Gentili F; Macdonald DR; Hariharan S; Cruz CR; Abrey LE
J Neurosurg; 2002 Aug; 97(2):341-6. PubMed ID: 12186462
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma.
Zhu H; Bi WL; Aizer A; Hua L; Tian M; Den J; Tang H; Chen H; Wang Y; Mao Y; Dunn IF; Xie Q; Gong Y
Cancer Med; 2019 Jan; 8(1):13-20. PubMed ID: 30680963
[TBL] [Abstract][Full Text] [Related]
17. Atypical and anaplastic meningiomas treated with bevacizumab.
Nayak L; Iwamoto FM; Rudnick JD; Norden AD; Lee EQ; Drappatz J; Omuro A; Kaley TJ
J Neurooncol; 2012 Aug; 109(1):187-93. PubMed ID: 22544653
[TBL] [Abstract][Full Text] [Related]
18. Surgical resection and permanent brachytherapy for recurrent atypical and malignant meningioma.
Ware ML; Larson DA; Sneed PK; Wara WW; McDermott MW
Neurosurgery; 2004 Jan; 54(1):55-63; discussion 63-4. PubMed ID: 14683541
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy, hormonal therapy, and immunotherapy for recurrent meningiomas.
Sioka C; Kyritsis AP
J Neurooncol; 2009 Mar; 92(1):1-6. PubMed ID: 19023520
[TBL] [Abstract][Full Text] [Related]
20. Molecular and translational advances in meningiomas.
Suppiah S; Nassiri F; Bi WL; Dunn IF; Hanemann CO; Horbinski CM; Hashizume R; James CD; Mawrin C; Noushmehr H; Perry A; Sahm F; Sloan A; Von Deimling A; Wen PY; Aldape K; Zadeh G;
Neuro Oncol; 2019 Jan; 21(Suppl 1):i4-i17. PubMed ID: 30649490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
